Novocure Transforms Patient Support System During Pandemic
Executive Summary
The company is running a pilot program to allow glioblastoma patients who use Novocure’s Optune Tumor Treating Fields device to download data from the device at home.
You may also be interested in...
JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the second day of the meeting.
Device Week, 25 September 2020 – Cognoa Develops Autism Detector; Longitude Launches New Fund
This episode of our weekly podcast covers Cognoa’s development of an app to detect autism spectrum disorder early, Novocure’s customer-focused business strategy during the pandemic, and the new $585m fund created by Longitude Capital to invest in medtech, pharma and biotech.
COVID-19 Impact: Young Doctors Rank Telehealth Above AI As Role Support Tool
Under-40s health care professionals’ attitudes have changed during COVID-19, and they want health care system to change too, according to a new report from Royal Philips.